thus enabling earlier treatment and improved slowing of the disease.

The NHS are set to launch a study to assess Alzheimer’s blood tests. If successful, blood tests could revolutionise the diagnosis of the disease, allowing for earlier diagnosis and subsequent treatment which would slow its progression. The NHS Blood Biomarker Challenge project is set to run for five years and has been backed by £5 million of funding. It seeks…